CRISPR Therapeutics AG logo

CRISPR Therapeutics AG

STU:1CG (Switzerland)   Ordinary Shares
€ 40.80 (0%) May 14
At Loss
P/B:
2.27
Market Cap:
€ 4.38B ($ 4.75B)
Enterprise V:
€ 2.65B ($ 2.87B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

CRISPR Therapeutics AG Operating Data

CRISPR Therapeutics AG Competitors' Latest Operating Data

Operating data not available.

CRISPR Therapeutics AG (STU:1CG) Operating Data Charts